ACSS2 and cancer: Several enzymes involved in de novo fatty acid synthesis, including FASN, ACLY, SCD, and ACSS2, are abnormally expressed in various cancers, promoting fatty acid synthesis and contributing to malignant tumor phenotypes [75–78].